carbazilquinone has been researched along with Anasarca in 1 studies
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A striking chemotherapeutically curative effect on tumor was obtained by means of temporary interruption of regional blood flow combined with local hyperthermia." | 1.26 | Temporary interruption of regional blood flow combined with local hyperthermia for cancer chemotherapy. ( Aoki, K; Baba, T; Kanematsu, T; Kidera, Y; Kimura, M, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, T | 1 |
| Aoki, K | 1 |
| Kidera, Y | 1 |
| Kimura, M | 1 |
| Kanematsu, T | 1 |
1 other study available for carbazilquinone and Anasarca
| Article | Year |
|---|---|
Temporary interruption of regional blood flow combined with local hyperthermia for cancer chemotherapy.
Topics: Animals; Antineoplastic Agents; Carbazilquinone; Carcinoma, Ehrlich Tumor; Chromomycins; Cyclophosph | 1976 |